EPDR1 Activators pertain to a category of chemical compounds that modulate or enhance the activity or expression of the ependymin-related protein 1 (EPDR1) gene. EPDR1, also known as MERP1, belongs to a family of proteins that share similarities with ependymins, which are glycoproteins associated with neuroplasticity in certain fish species. In humans, EPDR1 is less understood, but its expression patterns in various tissues suggest a potential role in cellular processes and molecular signaling pathways.
The mechanisms by which EPDR1 activators function can be diverse. Direct activators might interact specifically with the EPDR1 protein or its associated molecular partners, modulating its function or stability. These compounds could influence the protein's conformation, enhance its interaction with other proteins, or stabilize it against degradation. Alternatively, other activators might exert their effects at the genetic level, boosting the transcription of the EPDR1 gene, thereby increasing its mRNA and subsequent protein levels in the cell. Indirect activators might target upstream regulatory pathways or signaling molecules that converge on EPDR1, culminating in its enhanced activity or expression. Given the potential involvement of EPDR1 in various cellular functions, the interplay between these activators and the broader cellular milieu could be multifaceted and dynamic. The exploration and understanding of EPDR1 activators not only shed light on the specific molecular biology of this protein but also offer broader insights into cellular signaling and regulation mechanisms, emphasizing the intricate and interconnected nature of cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Known to elevate intracellular cAMP levels, which can influence various cellular pathways and might indirectly impact EPDR1 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
An inhibitor of phosphoinositide 3-kinase (PI3K) that might alter pathways indirectly influencing EPDR1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor which, by modulating associated pathways, could indirectly influence EPDR1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
While primarily an mTOR inhibitor, its broad cellular effects might indirectly impact EPDR1-associated pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, influencing various cellular signaling pathways that might have downstream effects on EPDR1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that alters intracellular calcium levels, potentially influencing pathways associated with EPDR1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
By raising intracellular calcium levels, this compound could influence calcium-responsive pathways indirectly affecting EPDR1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that might influence cellular pathways related to EPDR1. | ||||||